Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 7—July 2006
Research

Neisseria meningitidis Sequence Type and Risk for Death, Iceland

Magnús Gottfreðsson*†Comments to Author , Mathew A. Diggle‡, David I. Lawrie‡, Helga Erlendsdóttir*, Hjördís Harðardóttir*, Karl G. Kristinsson*†, and Stuart C. Clarke‡§
Author affiliations: *Landspítali University Hospital, Reykjavík, Iceland; †University of Iceland, Reykjavík, Iceland; ‡Scottish Meningococcus and Pneumococcus Reference Laboratory, Glasgow, United Kingdom; §University of Glasgow, Glasgow, United Kingdom

Main Article

Table 1

Description of the patient cohort

Parameter No. (%)
Patients 362
Male 185 (51.1)
Female 177 (48.9)
Children* 244 (67.4)
Adults 118 (32.6)
Strain isolated from cerebrospinal fluid only 144 (39.8)
Strain isolated from blood only 105 (29.0)
Strain isolated from cerebrospinal fluid and blood 78 (21.5)
Strain isolated from joint fluid 10 (2.8)
Strain grown from throat culture† 25 (6.9)
Serogroup A 8 (2.2)
Serogroup B 204 (56.4)
Serogroup C 144 (39.8)
Serogroup Y 3 (0.8)
Serogroup W135 3 (0.8)

*<16 years of age at the time of diagnosis.
†Positive throat culture in the setting of invasive meningococcal disease, diagnosed clinically.

Main Article

Page created: December 19, 2011
Page updated: December 19, 2011
Page reviewed: December 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external